Alec Stranahan
Stock Analyst at Bank of America Securities
(0.38)
# 4,516
Out of 5,118 analysts
680
Total ratings
42.4%
Success rate
-3%
Average return
Main Sectors:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $50 → $48 | $29.41 | +63.21% | 38 | Nov 6, 2026 | |
| ALEC Alector | Reiterated: Sell | $1 | $2.29 | -56.33% | 19 | Nov 6, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $35 → $24 | $6.93 | +246.32% | 3 | Nov 6, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $22 → $23 | $17.63 | +30.46% | 23 | Nov 6, 2026 | |
| MRNA Moderna | Reiterated: Hold | $220 → $260 | $254.19 | +2.29% | 32 | Nov 6, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Hold | $17 → $16 | $11.35 | +40.97% | 20 | Nov 6, 2026 | |
| NVAX Novavax | Reiterated: Sell | $8 → $7 | $10.78 | -35.06% | 46 | Nov 6, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $15 → $14 | $7.62 | +83.73% | 32 | Nov 6, 2026 | |
| SANA Sana Biotechnology | Reiterated: Buy | $6 | $2.37 | +153.16% | 14 | Nov 6, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $15 → $17 | $12.21 | +39.23% | 22 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $264 → $274 | $192.28 | +42.50% | 42 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $41 | $26.41 | +55.24% | 27 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $80 | $50.07 | +59.78% | 29 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $3.52 | +70.45% | 27 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $3.37 | +375.48% | 9 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $390 | $300.88 | +29.62% | 34 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $14.41 | +38.79% | 30 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $15.16 | +18.73% | 26 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $0.84 | +495.24% | 20 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $6.36 | +167.30% | 20 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $35.75 | -27.27% | 22 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $8.75 | +105.71% | 20 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.35 | +492.59% | 3 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $15.82 | +114.92% | 9 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $0.4487 | +1,014.33% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $9.00 | +111.11% | 17 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $88 | $75.99 | +15.80% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.57 | - | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $21 | $59.83 | -64.90% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $0.0075 | +13,233.33% | 1 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $800 → $565 | $904.35 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,150 → $1,100 | $1,354.00 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $23.70 | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $1 | $5.33 | n/a | 4 | Dec 2, 2022 |
Agios Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $50 → $48
Current: $29.41
Upside: +63.21%
Alector
Nov 6, 2026
Reiterated: Sell
Price Target: $1
Current: $2.29
Upside: -56.33%
Avalo Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $35 → $24
Current: $6.93
Upside: +246.32%
Janux Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $22 → $23
Current: $17.63
Upside: +30.46%
Moderna
Nov 6, 2026
Reiterated: Hold
Price Target: $220 → $260
Current: $254.19
Upside: +2.29%
Intellia Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $17 → $16
Current: $11.35
Upside: +40.97%
Novavax
Nov 6, 2026
Reiterated: Sell
Price Target: $8 → $7
Current: $10.78
Upside: -35.06%
REGENXBIO
Nov 6, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $7.62
Upside: +83.73%
Sana Biotechnology
Nov 6, 2026
Reiterated: Buy
Price Target: $6
Current: $2.37
Upside: +153.16%
Vir Biotechnology
Nov 6, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $12.21
Upside: +39.23%
Nov 5, 2026
Reiterated: Buy
Price Target: $264 → $274
Current: $192.28
Upside: +42.50%
Nov 4, 2026
Reiterated: Buy
Price Target: $43 → $41
Current: $26.41
Upside: +55.24%
Nov 4, 2026
Reiterated: Buy
Price Target: $81 → $80
Current: $50.07
Upside: +59.78%
Nov 4, 2026
Reiterated: Hold
Price Target: $6
Current: $3.52
Upside: +70.45%
Nov 4, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $3.37
Upside: +375.48%
Nov 2, 2026
Reiterated: Buy
Price Target: $400 → $390
Current: $300.88
Upside: +29.62%
Oct 27, 2026
Reiterated: Hold
Price Target: $20
Current: $14.41
Upside: +38.79%
Oct 27, 2026
Reiterated: Buy
Price Target: $18
Current: $15.16
Upside: +18.73%
Oct 26, 2026
Reiterated: Hold
Price Target: $5
Current: $0.84
Upside: +495.24%
Oct 26, 2026
Reiterated: Buy
Price Target: $17
Current: $6.36
Upside: +167.30%
Oct 26, 2026
Reiterated: Hold
Price Target: $26
Current: $35.75
Upside: -27.27%
Sep 30, 2026
Reiterated: Buy
Price Target: $18
Current: $8.75
Upside: +105.71%
Sep 30, 2026
Reiterated: Buy
Price Target: $8
Current: $1.35
Upside: +492.59%
Aug 14, 2026
Reiterated: Buy
Price Target: $34
Current: $15.82
Upside: +114.92%
Aug 14, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $0.4487
Upside: +1,014.33%
Aug 14, 2026
Reiterated: Buy
Price Target: $19
Current: $9.00
Upside: +111.11%
Aug 7, 2026
Reiterated: Buy
Price Target: $87 → $88
Current: $75.99
Upside: +15.80%
Aug 7, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.57
Upside: -
Aug 5, 2026
Reiterated: Sell
Price Target: $20 → $21
Current: $59.83
Upside: -64.90%
Mar 27, 2026
Reiterated: Sell
Price Target: $1
Current: $0.0075
Upside: +13,233.33%
Dec 10, 2024
Initiated Coverage: Sell
Price Target: $800 → $565
Current: $904.35
Upside: n/a
Nov 1, 2024
Rated: Buy
Price Target: $1,150 → $1,100
Current: $1,354.00
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: $6 → $5
Current: $23.70
Upside: n/a
Dec 2, 2022
Reiterated: Sell
Price Target: $10 → $1
Current: $5.33
Upside: n/a